A*STAR and Veredus Laboratories Create Market’s First Lab-on-Chip for the Detection of Multiple Tropical Infectious Diseases.

The Agency for Science, Technology and Research (A*STAR) and VeredusLaboratories announced the launch of VereTrop™, the first biochip in the molecular diagnostics market that can identify 13 different major tropical diseases, from a single blood sample.

More information

Veredus has appointed Xgenex as a distributor in U.S.A.

Veredus has appointed Xgenex as a distributor in U.S.A.

Veredus Laboratories Confirms that the VereFlu™ Lab-on-Chip Detects the Current Subtype of Avian Flu H7N9 in Addition to All Other Human Flu Subtypes

The current version of VereFlu detects the current subtype of H7N9 (Avian Flu) that is responsible for the Flu outbreak in China. H7N9 is the latest mutation to cause concern and increased surveillance in the region.

More information

Veredus will be exhibiting at the 44th Union World Conference on Lung Health in Paris, France from 30th October till 3rd November 2013.

Come visit us at Booth 56.

Click here for more information

Veredus Laboratories has confirmed in-silico that the current VereFlu™ panel is able to detect all H7 influenza strains, including the circulating H7N9 strain in China.

Veredus Laboratories has confirmed in-silico that the current VereFlu™ panel is able to detect all H7 influenza strains, including the circulating H7N9 strain in China.